arrow_back Back to App

Funding for Early Detection and Treatment of Uterine Fibroids and Gynecological Health.

This law authorizes federal grants to states to enhance early detection and intervention programs for uterine fibroids. Citizens, particularly those in vulnerable communities, will benefit from improved access to advanced screening procedures, patient support services, and public health education campaigns focused on gynecological health. The act also mandates research into disparities in pain management during surgical treatments.
Key points
Provides grants to states to fund early detection programs, including advanced gynecological imaging and payment for these procedures.
Prioritizes funding for states serving socially vulnerable populations with a higher risk of developing uterine fibroids.
Mandates research into evidence-based strategies for early detection and studies on disparities in pain control during surgical treatment.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_8247
Sponsor: Rep. Brown, Shontel M. [D-OH-11]
Process start date: 2024-05-06
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_8247.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-05-06.

What are the main provisions?

Key points include:

  • Provides grants to states to fund early detection programs, including advanced gynecological imaging and payment for these procedures.
  • Prioritizes funding for states serving socially vulnerable populations with a higher risk of developing uterine fibroids.
  • Mandates research into evidence-based strategies for early detection and studies on disparities in pain control during surgical treatment.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Brown, Shontel M. [D-OH-11].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health